Capecitabine: Supply issue resolved

There was a supply issue affecting both strengths, the 500 mg strength is available again and the 150 mg will be shortly.

Affected product

It was brought to our attention that there was a supply issue affecting capecitabine. We have confirmed with Dr Reddy's (the supplier) that it affected both strengths of the Capercit brand capecitabine tablets:

  • 150 mg Pharmacode 2578115
  • 500 mg Pharmacode 2578123

Schedule listing for capecitabine(external link)

Expected resupply

Dr Reddy's has expedited freight and expects shipments to arrive in New Zealand as follows:

  • 150 mg: 20 December 2022
  • 500 mg: as at 20 December, wholesalers can order from the supplier

Please note: It will take time for these shipments to clear quality assurance and make their way through the supply chain.

We expect that the listed Dr Reddy’s product will be available before alternative supply can be secured.

We appreciate supply issues like this can be inconvenient. Thank you for your patience.

Who to contact

If you have any questions about this supply issue, email enquiry@pharmac.govt.nz